Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3–4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment-Reference-Cited by-同舟云学术

Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3–4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment

Published:2020-10-01 Issue:10 Volume:26 Page:956-965
ISSN:1075-5535
Container-title:The Journal of Alternative and Complementary Medicine
language:en
Short-container-title:The Journal of Alternative and Complementary Medicine

Author:

Liu Yao¹,Li Yuxin¹,Wang Xiaojing¹,Huang Yunyi²,Zhang Qun¹,Shi Ke²,Ran Chongping¹,Hou Jie²,Wang Xianbo¹

Affiliation:

1. Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

2. Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Publisher

Mary Ann Liebert Inc

Subject

Complementary and alternative medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/acm.2019.0334

Reference27 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

2. Cancer statistics in China, 2015

3. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

5. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network Pharmacology to Reveal the Mechanism of Fufang Banmao Capsule for Treating Unresectable Primary Liver Cancer and Clinical Data Validation;Current Pharmaceutical Design;2024-10

2. Nanocrystals: Versatile Platform for Traditional Chinese Medicine Delivery;Current Drug Delivery;2024-08-20

3. Integrating Chinese medicine into mainstream cancer therapies: a promising future;Frontiers in Oncology;2024-06-18

4. Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease;Journal of Ethnopharmacology;2024-03

5. Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study;Frontiers in Pharmacology;2024-02-23